TASCENSO ODT FDA approval date

The FDA approved TASCENSO ODT on 23 Dec 2021.

FDA approval date
23 Dec 2021

Drug identity has not yet been verified against registry records

Also recorded as FINGOLIMOD LAURYL SULFATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-12-23DayTASCENSO ODTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214962", "applicant_as_listed_by_fda": "CYCLE", "brand_names": ["TASCENSO ODT"], "active_ingredients": ["FINGOLIMOD LAURYL SULFATE"], "submission_type": "ORIG", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20211223", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026